| | Mental Health | Schizophrenia
Neurotransmitters in Schizophrenia and Other Brain Disorders: Dopamine, Serotonin, and Beyond
Schizophrenia
Complex neurodevelopmental disorder. Dopamine hypothesis: Mesolimbic hyperactivity → positive symptoms (hallucinations, delusions); mesocortical hypoactivity → negative/cognitive symptoms. Serotonin (5-HT2A) modulation explains atypical antipsychotic efficacy. Glutamate (NMDA hypofunction) and GABA are also implicated.
Neurotransmitter Dysregulation Across Disorders
| Disorder | Key Neurotransmitter Changes |
|---|---|
| Parkinson's | Dopamine ↓ (substantia nigra degeneration) |
| Alzheimer's | Acetylcholine ↓ (basal forebrain), glutamate excitotoxicity |
| Depression | Serotonin ↓, norepinephrine ↓, dopamine ↓, BDNF ↓ |
| Anxiety | Serotonin ↓, GABA ↓, norepinephrine ↑, CRH ↑ |
Therapeutic Implications
Drugs target these systems: antipsychotics (D2/5-HT2A), levodopa (DA precursor), cholinesterase inhibitors (AChE), SSRIs/SNRIs (5-HT/NE reuptake), benzodiazepines (GABA-A). Precision psychiatry aims to match biology to treatment.
Schizophrenia - Related Articles
- Do Liars Have Better Memories? The Cognitive Cost of Deception
- Understanding Schizophrenia: Symptoms, Management & Support
- Understanding Negative Symptoms of Schizophrenia: A Comprehensive Guide
- Public Figures and Narcissism: Why Armchair Diagnosis Is Harmful
- Schizophrenia in Hispanic and Latinx Communities: Cultural Barriers and Strengths
- Reverse Psychology & Narcissism: Manipulation Tactics and Defense Strategies
- Schizophrenia Hospitalization: When It's Needed and What Happens
